COMPANY

Holobiome, Inc.

HQ: Boston, MA source · holobiome.org ↗ · New England

Location: Boston, MA · source · Oct 14, 2026

Profile checked Oct 10, 2026

Keywords: Sleep Disturbance Stress Feeling Anxious

Funding and NIH signals

SEC Form D raise Raised $10M (Form D filed Jul 22, 2026). SEC Form D 0001104659-26-085757 (Jul 22, 2026)
Evidence (1 event)
- Jul 22, 2026 · SEC Form D 0001104659-26-085757
  Name of Issuer: Holobiome, Inc.; CIK: 1763027; Address: Boston, MA; Submission type: D; Filing date: 2026-07-22; Industry Group: Biotechnology; Date of First Sale: 2025-12-24; Types of Securities Offered: Other (Simple Agreement for Future Equity (SAFES)); Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 10000000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

Aug 20, 2026 Trial start Not phased (device or behavioral study): GUT-FEELINGS: Using Citizen Science for Large-Scale Prebiotic Clinical Trials for Mental Health in Adults source ↗

2027-08 (ESTIMATED) · Not phased · GUT-FEELINGS: Using Citizen Science for Large-Scale Prebiotic Clinical Trials for Mental Health in Adults · NCT07752823

Estimated primary completion per ClinicalTrials.gov. Dates move.

Record	Title	Phase	Status	Start	Primary completion
NCT07752823	GUT-FEELINGS: Using Citizen Science for Large-Scale Prebiotic Clinical Trials for Mental Health in Adults	Not phased (device or behavioral study)	Not yet recruiting	Aug 20, 2026	2027-08 (estimated)

Annual award amounts. Total $3.4M.

Sep 22, 2021 NIH award 1R34NS126030-01 FY2021: $1,446,416 awarded for that fiscal year; activity R34 (OTHER_NIH); PI STRANDWITZ, PHILIP PETER; recipient as written: HOLOBIOME, INC., CAMBRIDGE, MA. Profiling the human gut microbio source ↗
Jul 5, 2021 NIH award 1R43DK127864-01A1 FY2021: $299,600 awarded for that fiscal year; activity R43 (SBIR); PI STRANDWITZ, PHILIP PETER; recipient as written: HOLOBIOME, INC., CAMBRIDGE, MA. Development of a therapeutic bacteria source ↗
Jun 10, 2021 NIH award 5R44DK120181-03 FY2021: $667,602 awarded for that fiscal year; activity R44 (SBIR); PI STRANDWITZ, PHILIP PETER; recipient as written: HOLOBIOME, INC., CAMBRIDGE, MA. Development of therapeutic GABA-produci source ↗
May 5, 2020 NIH award 4R44DK120181-02 FY2020: $664,418 awarded for that fiscal year; activity R44 (SBIR); PI STRANDWITZ, PHILIP PETER; recipient as written: HOLOBIOME, INC., CAMBRIDGE, MA. Development of therapeutic GABA-produci source ↗
May 29, 2019 NIH award 1R44DK120181-01A1 FY2019: $299,717 awarded for that fiscal year; activity R44 (SBIR); PI STRANDWITZ, PHILIP PETER; recipient as written: HOLOBIOME, INC., CAMBRIDGE, MA. Development of therapeutic GABA-produ source ↗